![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DG Schattenberg, WS Stillman, JJ Gruntmeir, KM Helm, RD Irons and D Ross
Molecular Toxicology and Environmental Health Sciences Program, School of Pharmacy, University of Colorado Health Sciences Center, Denver 80262.
Peroxidases may be important in the mechanism of toxicity of a number of compounds including benzene, a chemical that has been associated with bone marrow toxicity and leukemia after chronic exposure. The major peroxidase in bone marrow is myeloperoxidase (MPO), which has been previously thought to be expressed at the promyelocytic stage of differentiation. Hematopoietic progenitor cells are important potential cellular targets of bone marrow toxins and leukemogens. We therefore examined peroxidase activity in both murine and human progenitor cells. Murine progenitor populations were purified as lineage-negative cells (> 99% enriched) and human progenitor populations were purified as CD34+ cells (> 95% enriched). Using conventional biochemical assays for peroxidase activity, murine and human progenitor cells were found to have 30% and 11% of the peroxidase activity of murine and human unpurified marrow, respectively. Peroxidase activity was confirmed in purified murine and human progenitor populations by flow cytometry using a 2,7-dichlorofluorescein assay, adapted to measure peroxidase activity. In addition, two-color flow cytometry of murine whole marrow using phycoerythrin-conjugated antibodies to lineage markers confirmed the peroxidase activity of the murine progenitor cell population. A reverse transcription-polymerase chain reaction assay was developed for MPO mRNA, which was detected in murine progenitor cells. These data show that MPO mRNA is expressed in murine progenitor cells and that both murine and human progenitor cells have marked peroxidase activity. These data may have relevance for studies of hematopoietic cell differentiation and for the examination of mechanisms underlying cell- specific toxicity in bone marrow.
This article has been cited by other articles:
|
|
 |
|
  S. X. Liang, R. Summer, X. Sun, and A. Fine Gene expression profiling and localization of Hoechst-effluxing CD45- and CD45+ cells in the embryonic mouse lung Physiol Genomics, October 17, 2005; 23(2): 172 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hirabayashi, B.-I. Yoon, G.-X. Li, J. Kanno, and T. Inoue Mechanism of Benzene-Induced Hematotoxicity and Leukemogenicity: Current Review with Implication of Microarray Analyses Toxicol Pathol, February 1, 2004; 32(2_suppl): 12 - 16. [Abstract] [PDF]
|
|
|
|
 |
|
 M. H. Dahlke, O. S. Lauth, M. D. Jager, T. Roeseler, K. Timrott, S. Jackobs, M. Neipp, K. Wonigeit, and H. J. Schlitt In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody Blood, May 15, 2002; 99(10): 3566 - 3572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Smith, L. Zhang, M. Jeng, Y. Wang, W. Guo, P. Duramad, A. E. Hubbard, G. Hofstadler, and N. T. Holland Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells Carcinogenesis, August 1, 2000; 21(8): 1485 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Moran, D. Siegel, and D. Ross A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity PNAS, July 6, 1999; 96(14): 8150 - 8155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Young and J. Maciejewski The Pathophysiology of Acquired Aplastic Anemia N. Engl. J. Med., May 8, 1997; 336(19): 1365 - 1372. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ross Consulting the oracle: Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects Chen H and Eastmond DA Carcinogenesis, 1995; 16: 2301-2307 Human and Experimental Toxicology, March 1, 1996; 15(3): 272 - 274. [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
